Kurdoglu, MertihanKurdoglu, ZehraAdali, ErtanSoyoral, YaseminErkoc, Reha2025-05-102025-05-1020100932-00671432-071110.1007/s00404-009-1071-72-s2.0-71449101227https://doi.org/10.1007/s00404-009-1071-7https://hdl.handle.net/20.500.14720/9854Reha, Erkoc/0009-0001-7230-8843; Kurdoglu, Zehra/0000-0001-5191-1072; Kurdoglu, Mertihan/0000-0002-5344-9739We report the successful management of a pregnancy with preexisting nephrotic syndrome due to biopsy-proven primary membranoproliferative glomerulonephritis type I. A 21-year-old Turkish woman with membranoproliferative glomerulonephritis type I was followed up by the obstetrics and gynecology, and nephrology departments of a university hospital throughout her pregnancy starting from the 25th week of gestation. Due to progression of intrauterine growth retardation and fetal distress, a cesarean section was performed in the 33rd week of gestation. Although creatinine was unchanged, proteinuria increased with relatively stable albumin levels 3 months after delivery and her treatment was adjusted accordingly. If the mother is not suffering from hypertension or renal insufficiency, specific therapy for membranoproliferative glomerulonephritis type I during pregnancy provided by a nephrologist together with regular obstetric care may allow the patient to have a viable fetus, which might be growth retarded if proteinuria is increased.eninfo:eu-repo/semantics/closedAccessMembranoproliferative Glomerulonephritis Type IPregnancyManagementNephrotic SyndromeArticle2811Q3Q210510919357862WOS:000272017600020